Outcome of Board Meeting of Board of Directors held on 27th May, 2026 Consideration and Approval Audited Financial Result for the Quarter ended 31st March, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Achyut Healthcare Ltd reported audited financial results for FY26. Revenue from operations surged to Rs 1,159.47 lakhs from Rs 304.75 lakhs in FY25, representing over 280% growth driven by a preferential share issue of 58 lakh shares. However, net profit declined to Rs 31.57 lakhs from Rs 51.47 lakhs in the previous year, a drop of about 39%. EBITDA margin compressed significantly from 25.2% to approximately 4.7%, indicating substantial cost pressures relative to revenue. The company migrated to the BSE Main Board in January 2026 and adopted Ind AS for the first time this year. The statutory auditor issued an unmodified opinion with an emphasis of matter on the Ind AS transition. The board also approved related party transactions for FY27 and appointed new internal auditors.
Strong revenue growth was offset by margin compression and profit decline, suggesting operational efficiency challenges despite higher sales volumes. Shareholders may remain cautious given the disconnect between top-line growth and bottom-line performance.